The manufacturing process starts at the source. From donor screening and testing, to the sterile techniques applied during umbilical cord blood collection, as well as validated laboratory processing, every step of the way is conducted following strict standard operating procedures.
Cellgenic ensures proper methods are utilized to produce a clinical trial grade cellular therapy product. Safety has always been a primary concern for compliance and for the end user, your patients. Cellgenic’s culture has always been to go above and beyond every current guideline in order to ensure a clean and sterile product, free of contamination and cellular debris.
In the same fashion that the umbilical cord, placenta and amniotic fluid protect the growing baby and help it thrive, these biological cells have shown to be instrumental in helping repair and regenerate damaged tissues in the body.
Known as the “products of conception”, the regenerative materials from amniotic and umbilical tissue include the following:
The exact function of these materials supporting growth and health of the fetus is outside the scope of this guide. However, understand that a lot of the functions provided during fetal growth translate into patient benefit during regenerative procedures such as preventing infection and tissue growth of all types such as collagen, tendon, lung, kidney, heart, etc. These materials contain:
The list of conditions that may benefit from amniotic/umbilical procedures is extensive and continues to grow.
There are benefits being shown for:
We are using word HEAL as It is improper for ANYONE to provide an unrealistic expectation of what these therapies can do.No study shows 100% effectiveness, and more likely than not patients will see improvement and relief, but NOT a cure. The biologic elements in these materials work together to repair damaged tissue and also facilitate one’s own body to assist in the process as well. Just how much improvement is achieved depends on individual.
